OncoFlow has been accepted into the 2025 Caelestinus HealthTech Incubator
OncoFlow shared a post on LinkedIn:
“We are excited to announce that OncoFlow has been accepted into the 2025 Caelestinus HealthTech Incubator, powered by InterSystems!
This exciting opportunity will allow us to collaborate with leading experts and institutions in healthcare and tech, to enhance our mission of revolutionising cancer care with AI.
Massive thank you to the amazing team at Caelestinus InterSystems and so many partner institutions. Many exciting updates to come over the next 3 months for team OncoFlow!”
Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, shared this post, adding:
“It has been real hard work led by Maryam Hasanova and Igor Diev.
Pleasure being advised by Benjamin Lamb, Wayne Douglas, North East London Cancer Alliance, Akash Maniam, Gabriella Langton, Olubukola Ayodele, Ashraf Patel, Sarah Adomah, Nidhi Garg, Ankit Jain.”
More posts featuring OncoFlow and Aruni Ghose.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023